Aminothiazoles as FBPase inhibitors for diabetes
US7973051B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2008 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Nov 10, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I)as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.